Nanocarriers for the delivery of temozolomide in the treatment of glioblastoma: a review
Glioblastoma multiforme is the most common primary brain cancer and presents high morbidity and mortality. Its classic treatment consists of a combination of surgery, radiation and chemotherapy with temozolomide, an alkylating agent. However, in these aggressive tumors, this treatment is rarely succ...
| Autor principal: | |
|---|---|
| Outros Autores: | , |
| Formato: | book |
| Idioma: | eng |
| Publicado em: |
2017
|
| Texto completo: | https://hdl.handle.net/10216/116165 |
| País: | Portugal |
| Oai: | oai:repositorio-aberto.up.pt:10216/116165 |